Asparaginase and Cancer — Yesterday and Today

  • John G. Kidd
Part of the Recent Results in Cancer Research book series (RECENTCANCER, volume 33)

Keywords

Albumin Lymphoma Leukemia Electrophoresis Fractionation 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Kidd, John G.: A distinctive substance associated with the Brown-Pearce rabbit carcinoma. J. exp. Med. 71, 335–371 (1940).PubMedCrossRefGoogle Scholar
  2. 2.
    — Suppression of growth of the Brown-Pearce tumor by a specific antibody. Science 99, 348–350 (1944)PubMedCrossRefGoogle Scholar
  3. — J. exp. Med. 83, 227–250 (1946).CrossRefGoogle Scholar
  4. 3.
    MacKenzie, Ian, Kidd, John G.: Incidence and specificity of the antibody for a distinctive constituent of the Brown-Pearce tumor. J. exp. Med. 82, 41–63 (1945).PubMedCrossRefGoogle Scholar
  5. 4.
    Kalfayan, Bernard, Kidd, John G.: Structural changes produced in Brown-Pearce carcinoma cells by means of a specific antibody and complement. J. exp. Med. 97, 145–162 (1953).PubMedCrossRefGoogle Scholar
  6. 5.
    Kidd, John G.: Regression of transplanted lymphomas induced in vivo by means of normal guinea pig serum. I. Course of transplanted cancers of various kinds in mice and rats given guinea pig serum, horse serum or rabbit serum. J. exp. Med. 98, 565–582 (1953).PubMedCrossRefGoogle Scholar
  7. 6.
    — Regression of transplanted lymphomas induced in vivo by means of normal guinea pig serum. II. Studies on the nature of the active serum constituent: histological mechanism of the regression: tests for effects of guinea pig serum on lymphoma cells in vitro: Discussion. J. exp. Med. 98, 583–606 (1953).PubMedCrossRefGoogle Scholar
  8. 7.
    Todd, Jean Elizabeth: Inhibitory effects of normal guinea pig serum and immune rabbit serum on transplanted AKR lymphomas. Proc. Soc. exp. Biol. (N. Y.) 86, 781–785 (1954).Google Scholar
  9. 8.
    Todd, Jean Elizabeth, Kidd, John G.: Tests for isoantibodies active in conjunction with guinea pig serum against 6C3HED lymphoma cells. Proc. Soc. exp. Biol. (N. Y.) 86, 865–868 (1954).Google Scholar
  10. 9.
    Kauffman, Shirley L., Kidd, John G.: Effects of guinea pig serum on 6C3HED and AKRLI lymphoma cells implanted in various hosts. Proc. Soc. exp. Biol. (N. Y.) 91, 164–168 (1956).Google Scholar
  11. 10.
    Mohos, Steven C., Kidd, John G.: Effects of various immune rabbit serums on the cells of several transplanted mouse lymphomas in vitro and in vivo. With special reference to inhibition by an antibody that reacts with neoplastic and non-neoplastic lymphocytic cells of mice. J. exp. Med. 105, 233–265 (1957).PubMedCrossRefGoogle Scholar
  12. 11.
    Kidd, John G.: Effects of arsenic-azoproteins on mouse lymphoma cells in vivo. With observations on the effects of other “anti-lymphoma” agents, and on the susceptibility to these effects of lymphoma cells of various types. J. exp. Med. 108, 665–684 (1958).PubMedCrossRefGoogle Scholar
  13. 12.
    — Specificity and effects of antibodies that react with antigens of cancer cells. Acta Un. int. Cancr. 15, 921–923 (1959).PubMedGoogle Scholar
  14. 13.
    Clementi, A.: La desamidation enzymatique de L’asparagine chez les differentes especes animales et la signification physiologique de sa presence dans l’organisme. Arch. int. Physiol. 19, 369–398 (1922).CrossRefGoogle Scholar
  15. 14.
    Broome, J. D.: Evidence that the L-asparaginase activity of guinea pig serum is responsible for its antilymphoma effects. Nature 191, 1114–1115 (1961).CrossRefGoogle Scholar
  16. 15.
    — Evidence that the L-asparaginase of guinea pig serum is responsible for its antilymphoma effects. I. Properties of the L-asparaginase of guinea pig serum in relation to those of the antilymphoma substance. J. exp. Med. 118, 99–120 (1963).PubMedCrossRefGoogle Scholar
  17. 16.
    — Evidence that the L-asparaginase of guinea pig serum is responsible for its antilymphoma effects. II. Lymphoma 6C3HED cells cultured in a medium devoid of L-asparaginase lose their susceptibility to the effects of guinea pig serum in vivo. J. exp. Med. 118, 121–148 (1963).PubMedCrossRefGoogle Scholar
  18. 17.
    Mashburn, L. T., Wriston, John C., Jr.: Tumor inhibitory effect of L-asparaginase. Biochem. biophys. Res. Commun. 12, 50–55 (1963).CrossRefGoogle Scholar
  19. 18.
    Yellin, T. O., Wriston, John C., Jr.: Purification and properties of guinea pig serum asparaginase. Biochemistry 5, 1605–1612 (1966).PubMedCrossRefGoogle Scholar
  20. 19.
    Mashburn, L., Wriston, John C., Jr.: Tumor inhibitory effect of L-asparaginase from Escherichia coli. Arch. Biochem. 105, 450–452 (1964).PubMedCrossRefGoogle Scholar
  21. 20.
    Haley, E. E., Fischer, G. A., Welch, A. D.: The requirements for L-asparagine of mouse leukemia cells L5178 in culture. Cancer Res. 21, 532–536 (1961).PubMedGoogle Scholar
  22. 21.
    Sobin, L. H., Kidd, John G.: A metabolic difference between two lines of Lymphoma 6C3HED cells in relation to asparagine. Proc. Soc. exp. Biol. (N. Y.) 119, 325–327 (1965).Google Scholar
  23. 22.
    Kidd, John G. — — Alterations in protein and nucleic acid metabolism of Lymphoma 6C3HED-OG cells in mice given guinea pig serum. J. exp. Med. 123, 55–74 (1966).PubMedCrossRefGoogle Scholar
  24. 23.
    Kidd, John G., Sobin, Leslie H.: The incorporation of L-asparagine-14C by Lymphoma 6C3HED cells: inhibition by guinea pig serum. Cancer Res. 26, 208–211 (1966).PubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin • Heidelberg 1970

Authors and Affiliations

  • John G. Kidd
    • 1
  1. 1.The New York Hospital — Cornell Medical CenterNew YorkUSA

Personalised recommendations